Benefit Expectations and Neuroprotective Prescribing for Acute Ischemic Stroke in China

Consistently high benefit expectations, high perceived importance, and high familiarity are each linked to high-frequency neuroprotective prescribing for acute ischemic stroke among 1982 neurologists in mainland China.

• Why it matters: Neuroprotective therapies are widely used in China, but it is unclear how clinicians’ self-rated knowledge and beliefs relate to how often they prescribe them.
• What they did: A hospital-based quota survey (May 27–July 16, 2025) of attending or senior neurologists defined high-frequency use as prescribing to at least 60% of patients and used adjusted prevalence ratios from modified Poisson GEE.
• The result: High-frequency use was reported by 80.5%, while consistently high benefit expectations were reported by 65.1%; adjusted PRs were 1.053 for familiarity, 1.294 for importance, and 1.198 for benefit expectations.

AI summary of the abstract · may contain errors · not medical advice · read the paper.